脓毒症低血容量管理的专家声明
本文为脓毒症低血容量管理的专家声明,指出脓毒症患者低血容量常见且可能 contribute to worse outcome,但管理所依据的证据质量低。文中讨论了该领域的最新进展与争议,并针对脓毒症低血容量患者的液体治疗触发因素与目标、液体容量与类型给出专家声明。最后指出未解答的问题并提出未来研究路线图。
要点
- 脓毒症患者低血容量常见,且可能 contribute to worse outcome。
- 脓毒症低血容量管理受限于许多具体治疗环节证据质量低。
- 专家声明涵盖液体治疗的触发因素与目标。
- 专家声明涵盖液体容量与类型的选择。
- 文末指出未解答问题并提出未来研究路线图。
适用人群与场景
- 脓毒症患者,存在低血容量。
证据类型、等级与局限
- 证据类型:专家声明。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
指南或共识出处
- Expert statement for the management of hypovolemia in sepsis, Intensive Care Med.
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「研究设计与关键结果」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Hypovolemia is frequent in patients with sepsis and may contribute to worse outcome. The management of these patients is impeded by the low quality of the evidence for many of the specific components of the care. In this paper, we discuss recent advances and controversies in this field and give expert statements for the management of hypovolemia in patients with sepsis including triggers and targets for fluid therapy and volumes and types of fluid to be given. Finally, we point to unanswered questions and suggest a roadmap for future research.
参考来源
- Perner A, Cecconi M, Cronhjort M, et al. Expert statement for the management of hypovolemia in sepsis. Intensive Care Med. 2018. PMID: 29696295. doi:10.1007/s00134-018-5177-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。